These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33246970)

  • 21. Effect of IV alteplase on the ischemic brain lesion at 24-48 hours after ischemic stroke.
    Mair G; von Kummer R; Morris Z; von Heijne A; Bradey N; Cala L; Peeters A; Farrall AJ; Adami A; Potter G; Sandercock PAG; Lindley RI; Wardlaw JM;
    Neurology; 2018 Nov; 91(22):e2067-e2077. PubMed ID: 30366975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study.
    Amlie-Lefond C; deVeber G; Chan AK; Benedict S; Bernard T; Carpenter J; Dowling MM; Fullerton H; Hovinga C; Kirton A; Lo W; Zamel K; Ichord R;
    Lancet Neurol; 2009 Jun; 8(6):530-6. PubMed ID: 19423401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke.
    Cappellari M; Moretto G; Micheletti N; Donato F; Tomelleri G; Gulli G; Carletti M; Squintani GM; Zanoni T; Ottaviani S; Romito S; Tommasi G; Musso AM; Deotto L; Gambina G; Zimatore DS; Bovi P
    J Thromb Thrombolysis; 2014 May; 37(4):549-56. PubMed ID: 23943338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of Endovascular Thrombectomy with and without Thrombolysis for Acute Large Artery Ischaemic Stroke at a Tertiary Stroke Centre.
    Wee CK; McAuliffe W; Phatouros CC; Phillips TJ; Blacker D; Singh TP; Baker E; Hankey GJ
    Cerebrovasc Dis Extra; 2017; 7(2):95-102. PubMed ID: 28463832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial.
    Minhas JS; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Donnan GA; Kim JS; Lavados PM; Lee TH; Martins SCO; Olavarría VV; Pandian JD; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Thang NH; Wang JG; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Cerebrovasc Dis; 2018; 45(5-6):213-220. PubMed ID: 29705803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm.
    Chen X; Delcourt C; Sun L; Zhou Z; Yoshimura S; You S; Malavera A; Torii-Yoshimura T; Carcel C; Arima H; Hackett ML; Robinson T; Song L; Wang X; Lindley RI; Chalmers J; Anderson CS;
    Cerebrovasc Dis; 2020; 49(4):427-436. PubMed ID: 32702699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke.
    Menon BK; Al-Ajlan FS; Najm M; Puig J; Castellanos M; Dowlatshahi D; Calleja A; Sohn SI; Ahn SH; Poppe A; Mikulik R; Asdaghi N; Field TS; Jin A; Asil T; Boulanger JM; Smith EE; Coutts SB; Barber PA; Bal S; Subramanian S; Mishra S; Trivedi A; Dey S; Eesa M; Sajobi T; Goyal M; Hill MD; Demchuk AM;
    JAMA; 2018 Sep; 320(10):1017-1026. PubMed ID: 30208455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients.
    Li W; Lin L; Zhang M; Wu Y; Liu C; Li X; Huang S; Liang C; Wang Y; Chen J; Feng W
    Stroke; 2016 Oct; 47(10):2649-51. PubMed ID: 27608821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic drugs and ischaemic stroke.
    Prescrire Int; 2013 Nov; 22(143):270-1. PubMed ID: 24427842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischemic stroke.
    Wardlaw JM; von Kummer R; Carpenter T; Parsons M; Lindley RI; Cohen G; Murray V; Kobayashi A; Peeters A; Chappell F; Sandercock PA
    Int J Stroke; 2015 Aug; 10(6):956-68. PubMed ID: 23336348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial.
    Berge E; Cohen G; Roaldsen MB; Lundström E; Isaksson E; Rudberg AS; Slot KB; Forbes J; Smith J; Drever J; Wardlaw JM; Lindley RI; Sandercock PA; Whiteley WN;
    Lancet Neurol; 2016 Sep; 15(10):1028-34. PubMed ID: 27450474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endovascular Thrombectomy preceded by intravenous Alteplase versus endovascular Thrombectomy alone in Han Chinese patients treated for acute ischemic stroke with large vessel occlusion: a single-center retrospective analysis.
    Han R; Li B; Yue Y; Wu G; Yan X
    BMC Neurol; 2021 Sep; 21(1):375. PubMed ID: 34583639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
    Zhong CS; Beharry J; Salazar D; Smith K; Withington S; Campbell BCV; Wilson D; Le Heron C; Mason D; Duncan R; Reimers J; Mein-Smith F; Diprose WK; Barber PA; Ranta A; Fink JN; Wu TY
    Stroke; 2021 Mar; 52(3):1087-1090. PubMed ID: 33588597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orolingual angioedema after thrombolysis is not associated with insular cortex ischemia on pre-thrombolysis CT.
    Pinho J; Alves JN; Oliveira L; Pereira S; Barros J; Machado C; Amorim JM; Santos AF; Ribeiro M; Ferreira C
    J Neurol Sci; 2016 Oct; 369():48-50. PubMed ID: 27653864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Timing of Symptomatic Infarct Swelling Following Intravenous Thrombolysis in Acute Middle Cerebral Artery Infarction: A Case-Control Study.
    Lin TC; Lee JD; Lin YH; Yuan RY; Weng HH; Huang YC; Lee M; Wu CY; Hsu HL; Hsu CY; Lee TH; Liu SJ; Chang YJ; Chang CH; Peng TI; Liou CW; Chang KC; Pan YT; Huang YC
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):814-820. PubMed ID: 27443695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
    Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG;
    Lancet; 2019 Mar; 393(10174):877-888. PubMed ID: 30739745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    Campbell BCV; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Dowling RJ; Yan B; Bush SJ; Dewey HM; Thijs V; Scroop R; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Ang T; Miteff F; Levi CR; Rodrigues E; Zhao H; Salvaris P; Garcia-Esperon C; Bailey P; Rice H; de Villiers L; Brown H; Redmond K; Leggett D; Fink JN; Collecutt W; Wong AA; Muller C; Coulthard A; Mitchell K; Clouston J; Mahady K; Field D; Ma H; Phan TG; Chong W; Chandra RV; Slater LA; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Bladin CF; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM;
    N Engl J Med; 2018 Apr; 378(17):1573-1582. PubMed ID: 29694815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
    Logallo N; Novotny V; Assmus J; Kvistad CE; Alteheld L; Rønning OM; Thommessen B; Amthor KF; Ihle-Hansen H; Kurz M; Tobro H; Kaur K; Stankiewicz M; Carlsson M; Morsund Å; Idicula T; Aamodt AH; Lund C; Næss H; Waje-Andreassen U; Thomassen L
    Lancet Neurol; 2017 Oct; 16(10):781-788. PubMed ID: 28780236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orolingual angiodema associated with alteplase treatment of acute stroke: a reappraisal.
    Correia AS; Matias G; Calado S; Lourenço A; Viana-Baptista M
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):31-40. PubMed ID: 25440357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third International Stroke Trial.
    Lindley RI; Wardlaw JM; Whiteley WN; Cohen G; Blackwell L; Murray GD; Sandercock PA;
    Stroke; 2015 Mar; 46(3):746-56. PubMed ID: 25613308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.